Pharmacokinetic considerations for optimizing inhaled spray-dried pyrazinoic acid formulations.
Yeshwante SB, Hanafin P, Miller BK, Rank L, Murcia S, Xander C, Annis A, Baxter VK, Anderson EJ, Jermain B, Konicki R, Schmalstig AA, Stewart I, Braunstein M, Hickey AJ, Rao GG.
Yeshwante SB, et al. Among authors: annis a.
bioRxiv [Preprint]. 2023 Apr 3:2023.04.01.534965. doi: 10.1101/2023.04.01.534965.
bioRxiv. 2023.
PMID: 37066292
Free PMC article.
Updated.
Preprint.